Immunome (IMNM) Other Non-Current Assets (2019 - 2026)
Immunome (IMNM) reported Other Non-Current Assets of $210000.0 for Q1 2026, up 110.0% on a YoY basis from $100000.0 in Q1 2025, and up 5.0% quarter-over-quarter from $200000.0 in Q4 2025.
Immunome (IMNM) Other Non-Current Assets (2019 - 2026) Analysis & Trends
Immunome has reported Other Non-Current Assets for 8 years, with the latest figure at $210000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Assets rose 110.0% year-over-year to $210000.0; the trailing twelve-month figure through Mar 2026 stood at $210000.0 (up 110.0% YoY), and the FY2025 full-year result was $200000.0, down 95.47% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $210000.0, up from $200000.0 in the prior quarter.
- The five-year high for Other Non-Current Assets was $4.4 million in Q4 2024, with the low at $100000.0 in Q1 2022.
- Historically, Other Non-Current Assets has averaged $378294.1 across 5 years, with a median of $100000.0 in 2022.
- Annual changes were most pronounced in 2024 — Other Non-Current Assets jumped 4311.0% — and 2025, when it plunged 95.47%.
- Immunome's Other Non-Current Assets stood at $100000.0 in 2022, then changed by 0.0% to $100000.0 in 2023, then jumped by 4311.0% to $4.4 million in 2024, then sank by 95.47% to $200000.0 in 2025, then gained by 5.0% to $210000.0 in 2026.
- The last three Other Non-Current Assets figures came in at $210000.0 (Q1 2026), $200000.0 (Q4 2025), and $210000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 60,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Immunome | 2.12 Bn | 1.54 Bn | - | 210,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 210,000.00 |
| Dec 31, 2025 | 200,000.00 |
| Sep 30, 2025 | 210,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 4.41 Mn |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Dec 31, 2023 | 100,000.00 |
| Sep 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Mar 31, 2023 | 100,000.00 |
| Dec 31, 2022 | 100,000.00 |
| Sep 30, 2022 | 100,000.00 |
| Jun 30, 2022 | 100,000.00 |
| Mar 31, 2022 | 100,000.00 |
| Dec 31, 2021 | 332,000.00 |
| Sep 30, 2021 | 100,000.00 |
| Jun 30, 2021 | 100,000.00 |